Search Results - "Kelaidonis, Konstantinos"

Refine Results
  1. 1
  2. 2

    From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy by Matsoukas, John, Apostolopoulos, Vasso, Zulli, Anthony, Moore, Graham, Kelaidonis, Konstantinos, Moschovou, Kalliopi, Mavromoustakos, Thomas

    Published in Molecules (Basel, Switzerland) (25-01-2021)
    “…The octapeptide hormone angiotensin II is one of the most studied peptides with the aim of designing and synthesizing non-peptide mimetics for oral…”
    Get full text
    Journal Article
  3. 3

    Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy by Ridgway, Harry, Chasapis, Christos T, Kelaidonis, Konstantinos, Ligielli, Irene, Moore, Graham J, Gadanec, Laura Kate, Zulli, Anthony, Apostolopoulos, Vasso, Mavromoustakos, Thomas, Matsoukas, John M

    Published in Viruses (11-05-2022)
    “…SARS-CoV-2 is a global challenge due to its ability to mutate into variants that spread more rapidly than the wild-type virus. Because the molecular biology of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity by Ridgway, Harry, Ntallis, Charalampos, Chasapis, Christos T, Kelaidonis, Konstantinos, Matsoukas, Minos-Timotheos, Plotas, Panagiotis, Apostolopoulos, Vasso, Moore, Graham, Tsiodras, Sotirios, Paraskevis, Dimitrios, Mavromoustakos, Thomas, Matsoukas, John M

    Published in Viruses (22-01-2023)
    “…, , , , Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global challenge due to its ability to mutate into variants that spread more rapidly…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019 by Swiderski, Jordan, Gadanec, Laura Kate, Apostolopoulos, Vasso, Moore, Graham J, Kelaidonis, Konstantinos, Matsoukas, John M, Zulli, Anthony

    Published in Biomolecules (Basel, Switzerland) (02-05-2023)
    “…Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality. Major pathogenic phenotypes of CVDs include the development of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19 by Moore, Graham J., Pires, Jose M., Kelaidonis, Konstantinos, Gadanec, Laura Kate, Zulli, Anthony, Apostolopoulos, Vasso, Matsoukas, John M.

    Published in Biomolecules (Basel, Switzerland) (03-07-2021)
    “…Angiotensin II (Ang II) may contain a charge relay system (CRS) involving Tyr/His/carboxylate, which creates a tyrosinate anion for receptor activation. Energy…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan by Matsoukas, John M, Ligielli, Irene, Chasapis, Christos T, Kelaidonis, Konstantinos, Apostolopoulos, Vasso, Mavromoustakos, Thomas

    Published in Brain sciences (29-11-2021)
    “…Multiple Sclerosis (MS) is a serious autoimmune disease. The patient in an advanced state of the disease has restrained mobility and remains handicapped. It is…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases by Chasapis, Christos T, Kelaidonis, Konstantinos, Ridgway, Harry, Apostolopoulos, Vasso, Matsoukas, John M

    Published in Brain sciences (24-03-2022)
    “…Myelin in humans is composed of about 80% lipids and 20% protein. Initially, myelin protein composition was considered low, but various recent proteome…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20